Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults and Boost (VXA-CoV2-1.1-S) at 1 Year Post Initial Vaccination in Subset of Subjects
Clinical trial NCT04563702 · COMPLETED
Trial details
- NCT number
- NCT04563702
- Sponsor
- Vaxart
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-21
- Primary completion
- 2021-10-10
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.